new version V2017

ovarian cancer

     

TrialStudied treatmentControl treatmentpatientsROBResultNCT

poly ADP-ribose polymerase (PARP) inhibitor

niraparib
ENGOT-OV16/NOVA non-gBRCAniraparibplacebo Low risk of bias SuggestingNCT01847274
ENGOT-OV16/NOVA gBRCA, 2017niraparibplacebo Low risk of bias SuggestingNCT01847274
olaparib
SOLO2/ENGOT-Ov21olaparibplacebo Low risk of bias SuggestingNCT01874353
Ledermann, 2012olaparidplacebo Exploratory SuggestingNCT00753545
rucaparib
ARIEL 4 ongoing rucaparibchemotherapyRelapsed BRCA Mutant Risk of bias - NCT02855944
ARIEL 3 ongoing rucaparibplacebo Low risk of bias - NCT01968213